SAN FRANCISCO — Risuteganib showed potential for the treatment of intermediate dry age-related macular degeneration, according to study results presented at Retina Subspecialty Day prior to the American Academy of Ophthalmology annual meeting.“The path…
Improved method for predicting retinopathy of prematurity could reduce unnecessary tests
A multicenter group of 41 hospitals led by researchers at Children’s Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the…
Second Sight Reports Third Quarter 2019 Financial Results
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
Patients achieve successful outcomes after Baerveldt implantation by residents
Patients with glaucoma who underwent Baerveldt implantation by residents experienced similar outcomes and IOP reduction 1 year postoperatively when compared with implantations performed by glaucoma specialists, according to a study.“When compared with …
Reduce your 2019 tax bill before year’s end
by Sanjeev Bhatia, MD, and David Mandell, JD, MBAMany physicians have just filed their 2018 tax returns – if they filed on extension – but it is already time to take steps to reduce the 2019 tax bill. In fact, year-end planning is important because man…
FDA warns Dollar Tree regarding ‘potentially unsafe’ drugs
The FDA has sent a warning letter to Greenbrier International, Inc., doing business as Dollar Tree, for receiving over-the-counter drugs made by foreign manufacturers that were found to have serious violations of federal law.According to the press rele…